D-687-2013 Class II Terminated
FDA drug recall D-687-2013 was initiated by Sun Pharmaceutical Industries Inc. on May 21, 2013 and is designated Class II. Reason for recall: Crystallization; crystallized nimodipine The recall status is terminated (terminated Aug 25, 2014). Affected quantity: 46387 Cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 17, 2013
- Initiation Date
- May 21, 2013
- Termination Date
- Aug 25, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 46387 Cartons
Product description
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
Reason for recall
Crystallization; crystallized nimodipine
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #s: a) 3305.036B, 3305.037B, Exp Jun-13; 3505.041B, Exp Sep-13; 3305.043B, Exp Nov-13; 3305.044B, Exp Dec-13; 3305.045B Mar-14. Lot #s: b) 3305.036A, 3305.037A, Exp Jun-13; 3305.038A, Exp Jul-13; 3305.040A, 3505.041A Exp Sep-13; 3305.042A, 3305.043A, Exp Nov-13; 3305.044A Dec-13.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-687-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026